• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A型肉毒神经毒素功能域抗原的免疫特性及免疫保护效力

Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.

机构信息

Beijing Institute of Biotechnology, Beijing 100071, China; Pharmaceutical College, Henan University, Kaifeng 475001, China.

Beijing Institute of Biotechnology, Beijing 100071, China.

出版信息

Vaccine. 2020 Mar 23;38(14):2978-2983. doi: 10.1016/j.vaccine.2020.02.060. Epub 2020 Feb 26.

DOI:10.1016/j.vaccine.2020.02.060
PMID:32113807
Abstract

Botulinum neurotoxins (BoNTs) are highly toxic proteins that mediate their effects by binding to neuronal receptors and block the neutralizing ability of therapeutic antibodies. Vaccination is currently the most effective strategy to prevent botulism. In this study, a series of recombinant functional domain antigens of BoNT/A were prepared and identified, and their immunoprotective efficacies were explored and compared. Our results showed that all antigens produced strong humoral immune responses, although their protective effects against the toxin were different. Only the Hc and HN-L antigens produced strong protective effects and afforded complete immunoprotection. In addition, the combined vaccine groups showed that there was no synergistic effect on immune responses after antigen combination, suggesting that the integrity of the toxin antigen or domain is crucial to the immune effects. Studies of the dose-dependent immunoprotective effects further confirmed that the Hc domain antigen afforded more effective protective potency than the HN-L antigen, equivalent to the immune effect of the full-length toxin (Hc + HN-L combination group). Overall, our results demonstrated that the Hc domain elicited a strong protective immune response and also provided basic data and theoretical support for the development of Hc-based BoNT/A subunit vaccine. Therefore, the receptor binding domain Hc is implicated as a promising target antigen of the BoNT/A recombinant subunit vaccine as an alternative to the toxoid vaccine.

摘要

肉毒神经毒素(BoNTs)是高度毒性的蛋白质,通过与神经元受体结合来发挥作用,并阻止治疗性抗体的中和能力。疫苗接种是预防肉毒中毒的最有效策略。在这项研究中,制备并鉴定了一系列 BoNT/A 的重组功能结构域抗原,并探索和比较了它们的免疫保护效力。我们的结果表明,所有抗原都产生了强烈的体液免疫反应,尽管它们对毒素的保护效果不同。只有 Hc 和 HN-L 抗原产生了强烈的保护作用,并提供了完全的免疫保护。此外,联合疫苗组表明,抗原组合后免疫反应没有协同作用,这表明毒素抗原或结构域的完整性对于免疫效果至关重要。对剂量依赖性免疫保护效果的研究进一步证实,Hc 结构域抗原比 HN-L 抗原提供了更有效的保护效力,相当于全长毒素的免疫效果(Hc+HN-L 联合组)。总的来说,我们的结果表明 Hc 结构域引发了强烈的保护性免疫反应,为基于 Hc 的 BoNT/A 亚单位疫苗的开发提供了基本数据和理论支持。因此,受体结合结构域 Hc 被认为是 BoNT/A 重组亚单位疫苗的有前途的靶抗原,可替代类毒素疫苗。

相似文献

1
Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.A型肉毒神经毒素功能域抗原的免疫特性及免疫保护效力
Vaccine. 2020 Mar 23;38(14):2978-2983. doi: 10.1016/j.vaccine.2020.02.060. Epub 2020 Feb 26.
2
Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B.开发和评估针对 B 型肉毒神经毒素的候选亚单位疫苗。
Hum Vaccin Immunother. 2019;15(3):755-760. doi: 10.1080/21645515.2018.1547613. Epub 2018 Dec 4.
3
Recombinant L-HN Fusion Antigen Derived from the L and HN Domains of Botulinum Neurotoxin B Stimulates a Protective Antibody Response Against Active Neurotoxin.重组 L-HN 融合抗原来源于肉毒神经毒素 B 的 L 和 HN 结构域,可刺激针对活性神经毒素的保护性抗体应答。
Neurotox Res. 2021 Aug;39(4):1044-1053. doi: 10.1007/s12640-021-00337-x. Epub 2021 Feb 22.
4
Production and evaluation of a recombinant subunit vaccine against botulinum neurotoxin serotype B using a 293E expression system.使用293E表达系统生产和评估抗B型肉毒杆菌神经毒素的重组亚单位疫苗。
Hum Vaccin Immunother. 2015;11(2):468-73. doi: 10.4161/hv.29714.
5
Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E.E 型肉毒神经毒素候选亚单位疫苗和新型抗毒素的研发与评价。
Hum Vaccin Immunother. 2020;16(1):100-108. doi: 10.1080/21645515.2019.1633878. Epub 2019 Jul 26.
6
Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E.功能性 EL-HN 片段作为预防肉毒梭菌神经毒素血清型 E 的有效候选疫苗。
Toxins (Basel). 2022 Feb 11;14(2):135. doi: 10.3390/toxins14020135.
7
Enhancing toxin-based vaccines against botulism.增强基于毒素的肉毒梭菌疫苗。
Vaccine. 2018 Feb 1;36(6):827-832. doi: 10.1016/j.vaccine.2017.12.064. Epub 2018 Jan 4.
8
Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.通过体内靶向抗原呈递细胞实现对肉毒杆菌神经毒素 Hc 亚单位疫苗的快速免疫应答。
Infect Immun. 2011 Aug;79(8):3388-96. doi: 10.1128/IAI.00166-11. Epub 2011 May 16.
9
Protective potential of recombinant non-purified botulinum neurotoxin serotypes C and D.重组非纯化肉毒杆菌神经毒素C型和D型的保护潜力
Anaerobe. 2016 Aug;40:58-62. doi: 10.1016/j.anaerobe.2016.05.012. Epub 2016 May 25.
10
Recombinant Botulinum Neurotoxin Hc Subunit (BoNT Hc) and Catalytically Inactive Clostridium botulinum Holoproteins (ciBoNT HPs) as Vaccine Candidates for the Prevention of Botulism.重组肉毒神经毒素 Hc 亚单位(BoNT Hc)和无活性的梭状芽胞杆菌全毒素(ciBoNT HPs)作为预防肉毒中毒的疫苗候选物。
Toxins (Basel). 2017 Sep 3;9(9):269. doi: 10.3390/toxins9090269.

引用本文的文献

1
Humanized VHH-hFc Fusion Proteins Targeting the L-HN Fragment of Tetanus Toxin Provided Protection In Vivo.靶向破伤风毒素L-HN片段的人源化VHH-hFc融合蛋白在体内提供保护。
Antibodies (Basel). 2025 Jun 13;14(2):48. doi: 10.3390/antib14020048.
2
Effectiveness of a Bivalent Recombinant Vaccine on the Production of Neutralizing Antibodies Against BoNT/C, BoNT/D, BoNT/CD e BoNT/DC in Bovines.一种二价重组疫苗对牛产生抗肉毒杆菌毒素C、肉毒杆菌毒素D、肉毒杆菌毒素CD和肉毒杆菌毒素DC中和抗体的有效性。
Vaccines (Basel). 2025 Mar 11;13(3):299. doi: 10.3390/vaccines13030299.
3
A novel single-domain antibody obtained from immune Bactrian camels against botulinum toxin type A using SPR-based screening method.
一种通过基于表面等离子体共振(SPR)的筛选方法从免疫双峰驼中获得的新型抗A型肉毒杆菌毒素单域抗体。
Heliyon. 2025 Feb 14;11(4):e42616. doi: 10.1016/j.heliyon.2025.e42616. eCollection 2025 Feb 28.
4
Neutralizing chimeric heavy-chain antibody targeting the L-HN domain of Clostridium botulinum neurotoxin type F.针对肉毒梭菌神经毒素型 F 的 L-HN 结构域的中和嵌合重链抗体。
Arch Toxicol. 2024 Dec;98(12):4187-4195. doi: 10.1007/s00204-024-03869-1. Epub 2024 Sep 23.
5
A human bispecific antibody neutralizes botulinum neurotoxin serotype A.一种人源双特异性抗体中和 A 型肉毒神经毒素。
Sci Rep. 2023 Nov 27;13(1):20806. doi: 10.1038/s41598-023-48008-5.
6
Tetanus toxin and botulinum neurotoxin-derived fusion molecules are effective bivalent vaccines.破伤风毒素和肉毒神经毒素衍生的融合分子是有效的双价疫苗。
Appl Microbiol Biotechnol. 2023 Dec;107(23):7197-7211. doi: 10.1007/s00253-023-12796-7. Epub 2023 Sep 23.
7
Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.基于 BoNTs 受体结合结构域的新型四价肉毒毒素中和抗体的鉴定。
Appl Microbiol Biotechnol. 2023 May;107(10):3205-3216. doi: 10.1007/s00253-023-12515-2. Epub 2023 Apr 14.
8
Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F.功能性 L-HN 衍生型 F 型肉毒神经毒素的生物学和免疫学特性。
Toxins (Basel). 2023 Mar 6;15(3):200. doi: 10.3390/toxins15030200.
9
A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A.一种基于 A 型肉毒神经毒素重组蛋白的热稳定溶解微针疫苗。
Toxins (Basel). 2022 Dec 16;14(12):881. doi: 10.3390/toxins14120881.
10
Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E.功能性 EL-HN 片段作为预防肉毒梭菌神经毒素血清型 E 的有效候选疫苗。
Toxins (Basel). 2022 Feb 11;14(2):135. doi: 10.3390/toxins14020135.